Sort
51,593 grants matching “hepatitis”
Molecular Mechanisms of Postnatal Islet alpha-cell Proliferation
$557,663Wenbiao Chen · Vanderbilt University · R01 · FY2022 · DK
Molecular Mechanisms of Postnatal Islet alpha-cell Proliferation
$557,663Wenbiao Chen · Vanderbilt University · R01 · FY2023 · DK
Durable Schistosome induced metabolic alterations to the myeloid lineage
$557,562Keke Celeste Fairfax · University Of Utah · R01 · FY2024 · AI
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
$557,551Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2024 · DK
CLINICAL IMPACT ON HCV &ALCOHOL IN HIV INFECTED PERSONS
$557,514Boston Medical Center · R01 · FY2000 · AA
Metabolic and Cognitive Consequences of Sleep Loss
$557,441Kenneth P Wright · University Of Colorado · R01 · FY2011 · HL
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care
$557,431Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2018 · DA
Positive Immune-regulators During Chronic Viral Infections
$557,397Elina I Zuniga · University Of California, San Diego · R01 · FY2020 · AI
A Novel Stem Cell-based Approach for Generating Non-Human Primate Livers in Pigs
$557,273Clifford J. Steer · University Of Minnesota · R01 · FY2018 · DK
Rewiring Pathways and Networks by Environmental Perturbations
$557,204Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2009 · ES
Rewiring Pathways and Networks by Environmental Perturbations
$557,204Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2008 · ES
Regulation of hepatic hepcidin expression by transferrin receptor-2
$557,187Caroline Enns · Oregon Health & Science University · R01 · FY2021 · DK
Molecular Evolution Strategies to Derive New Recombinant AAV Vectors
$557,152Mark A Kay · Stanford University · R01 · FY2010 · HL
Microfluidic organoid model of cardio-hepatic physiology and disease
$557,067David Sachs · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
Alcohol Reduction in Medical Illnesses:HCV as Prototype
$557,054Case Western Reserve University · R01 · FY2004 · AA
MRI-based Quantitative Susceptibility Mapping of Hepatic Iron Overload
$557,050Diego Hernando · University Of Wisconsin-Madison · R01 · FY2020 · DK
Pathogenesis of Liver Disease in Hepatitis
$556,979Scripps Research Institute · R01 · FY2004 · AI
Outcome of NASH in Adolescents after Bariatric Surgery vs. Lifestyle Intervention
$556,845Stavra Xanthakos · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · DK
Outcome of NASH in Adolescents after Bariatric Surgery vs. Lifestyle Intervention
$556,844Stavra Xanthakos · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · DK
Fatigue in HIV-Positive People
$556,830Julie V Barroso · Duke University · R01 · FY2006 · NR
DEVELOPMENT OF THE HBcAG AS A VACCINE CARRIER PLATFORM
$556,773Vaccine Research Institute Of San Diego · R01 · FY2004 · AI
Role of cholesterol in the pathogenesis of hepatic encephalopathy
$556,767Sharon Demorrow · University Of Texas At Austin · R01 · FY2024 · DK
Mechanisms of hepatic innate immune activation by HCV
$556,742Michael J Gale · University Of Washington · R01 · FY2017 · AI
Obesity, chemotherapy dosing, and breast cancer outcomes
$556,735Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2021 · CA
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS
$556,682Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2013 · HL